UK markets open in 7 hours 3 minutes

Koninklijke Philips NV (PHI1.HA)

Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
24.09+0.25 (+1.05%)
At close: 08:04AM CEST
Full screen
Previous close23.84
Open24.09
Bid24.04 x 0
Ask24.07 x 0
Day's range24.09 - 24.09
52-week range16.18 - 27.90
Volume16
Avg. volume9
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Yahoo Finance Video

    Eli Lilly seeks to expand Zepbound use to treat sleep apnea

    Eli Lilly (LLY) is reporting success in the use of Zepbound — one of the pharmaceutical giant's landmark GLP-1 weight-loss drugs — to treat sleep apnea. Yahoo Finance Health Reporter Anjalee Khemlani joins The Morning Brief to discuss Eli Lilly's filing for approval from the US Food and Drug Administration (FDA) for this use case and how it may affect makers of CPAP (Continuous Positive Airway Pressure) sleep devices, such as Philips (PHG) and ResMed (RMD). For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • Yahoo Finance Video

    Philips NA CEO on alleviating healthcare worker burnout

    The healthcare industry faces multiple challenges, including the challenge of filling healthcare jobs. The stress of labor shortages could be causing employee burnout and may be impacting patient care, according to the Philips 2024 Future Health Index survey. Philips (PHG) North America CEO Jeff DiLullo joins Wealth! alongside Yahoo Finance Reporter Anjalee Khemlani to give insight into the current landscape of the labor market within the healthcare sector. DiLullo elaborates on the process in which many nurses and doctors are feeling burnout, specifically with how they must learn new technologies to process patient information. He claims Philips helps by simplifying that process: "From Philips' perspective, interoperability is the name of the game. If you think about the journey that we're on, you need the technology and the innovation, but it has to be organized in a way. CEOs and CIOs will tell me, 'don't kill me by a death by a thousand cuts, orchestrate it for me.' That's why we're proud to lead in our orchestration of that with an informatics platform that can look at extracting from the device, liquidating and organizing that data along the care path to interact with doctors wherever they are, not always in a hospital. " For more expert insight and the latest market action, click here to watch this full episode of Wealth! This post was written by Nicholas Jacobino

  • Yahoo Finance Video

    Philips stock jumps on settlement: CEO explains what's next

    Koninklijke Philips (PHG) reached a $1.1 billion settlement over a US device recall for its respiratory ventilator devices, causing shares of the company to jump on Monday. The payment was originally estimated by some analysts to be more than $2 billion, putting to bed many worries from investors. However, the company still faces investigations, including one by the US Department of Justice.  Philips CEO Roy Jakobs speaks with Yahoo Finance's Anjalee Khemlani to give insight into the settlement and how his company will operate moving forward with other investigations. Jakobs affirms: "So by actually closing the settlement, we have taken the vast majority of the cases out of the way, especially the three litigation cases that were there in the US: economic loss, personal injury, and medical monitoring. Actually that is the closed chapter now, and that was very important because actually the biggest uncertainty was tied to that. It is true that still the DOJ is remaining. We are fully collaborating with that, giving the information requested, there's no further clarity on what that would mean and when they would come toward." For more expert insight and the latest market action, click here to watch this full episode of Wealth! This post was written by Nicholas Jacobino